Literature DB >> 31119735

Genome-wide linkage analysis and whole-exome sequencing identifies an ITGA2B mutation in a family with thrombocytopenia.

Rami Khoriaty1,2,3, Ayse B Ozel4, Shweta Ramdas5, Charles Ross6, Karl Desch7, Jordan A Shavit7, Lesley Everett4, David Siemieniak8, Jun Z Li4,5, David Ginsburg1,4,7,8,9.   

Abstract

Hereditary thrombocytopenias can be subclassified based on mode of inheritance and platelet size. Here we report a family with autosomal dominant (AD) thrombocytopenia with normal platelet size. Linkage analysis and whole exome sequencing identified the R1026W substitution in ITGA2B as the causative defect. The same mutation has been previously reported in 7 Japanese families/patients with AD thrombocytopenia, but all of these patients had macrothrombocytopenia. This is the first report of a family with AD thrombocytopenia with normal platelet size resulting from mutation in ITGA2B. ITGA2B mutations should therefore be included in the differential diagnosis of this latter disorder.
© 2019 British Society for Haematology and John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990ITGA2Bzzm321990; autosomal dominant thrombocytopenia; hereditary thrombocytopenia; linkage analysis; whole exome sequencing

Mesh:

Substances:

Year:  2019        PMID: 31119735      PMCID: PMC6679728          DOI: 10.1111/bjh.15961

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

1.  A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder.

Authors:  R Hardisty; D Pidard; A Cox; T Nokes; C Legrand; C Bouillot; A Pannocchia; E Heilmann; P Hourdillé; S Bellucci
Journal:  Blood       Date:  1992-08-01       Impact factor: 22.113

Review 2.  Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models.

Authors:  Alan T Nurden; Mathieu Fiore; Paquita Nurden; Xavier Pillois
Journal:  Blood       Date:  2011-09-13       Impact factor: 22.113

3.  Heterozygous ITGA2B R995W mutation inducing constitutive activation of the αIIbβ3 receptor affects proplatelet formation and causes congenital macrothrombocytopenia.

Authors:  Shinji Kunishima; Hirokazu Kashiwagi; Makoto Otsu; Naoya Takayama; Koji Eto; Masafumi Onodera; Yuji Miyajima; Yasushi Takamatsu; Junji Suzumiya; Kousaku Matsubara; Yoshiaki Tomiyama; Hidehiko Saito
Journal:  Blood       Date:  2011-03-31       Impact factor: 22.113

4.  Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes.

Authors:  Jesse W Rowley; Andrew J Oler; Neal D Tolley; Benjamin N Hunter; Elizabeth N Low; David A Nix; Christian C Yost; Guy A Zimmerman; Andrew S Weyrich
Journal:  Blood       Date:  2011-05-19       Impact factor: 22.113

Review 5.  Genetics of familial forms of thrombocytopenia.

Authors:  Carlo L Balduini; Anna Savoia
Journal:  Hum Genet       Date:  2012-08-11       Impact factor: 4.132

6.  A nonsynonymous SNP in the ITGB3 gene disrupts the conserved membrane-proximal cytoplasmic salt bridge in the alphaIIbbeta3 integrin and cosegregates dominantly with abnormal proplatelet formation and macrothrombocytopenia.

Authors:  Cedric Ghevaert; Alexandre Salsmann; Nicholas A Watkins; Elisabeth Schaffner-Reckinger; Angela Rankin; Stephen F Garner; Jonathan Stephens; Graham A Smith; Najet Debili; William Vainchenker; Philip G de Groot; James A Huntington; Mike Laffan; Nelly Kieffer; Willem H Ouwehand
Journal:  Blood       Date:  2007-12-07       Impact factor: 22.113

7.  Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families.

Authors:  Paolo Gresele; Emanuela Falcinelli; Silvia Giannini; Pio D'Adamo; Angela D'Eustacchio; Teresa Corazzi; Anna Maria Mezzasoma; Filomena Di Bari; Giuseppe Guglielmini; Luca Cecchetti; Patrizia Noris; Carlo L Balduini; Anna Savoia
Journal:  Haematologica       Date:  2009-03-31       Impact factor: 9.941

8.  Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2.

Authors:  Tommaso Pippucci; Anna Savoia; Silverio Perrotta; Núria Pujol-Moix; Patrizia Noris; Giovanni Castegnaro; Alessandro Pecci; Chiara Gnan; Francesca Punzo; Caterina Marconi; Samuele Gherardi; Giuseppe Loffredo; Daniela De Rocco; Saverio Scianguetta; Serena Barozzi; Pamela Magini; Valeria Bozzi; Luca Dezzani; Mariateresa Di Stazio; Marcella Ferraro; Giovanni Perini; Marco Seri; Carlo L Balduini
Journal:  Am J Hum Genet       Date:  2011-01-07       Impact factor: 11.025

9.  Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation.

Authors:  Dominique Bluteau; Alessandra Balduini; Nathalie Balayn; Manuela Currao; Paquita Nurden; Caroline Deswarte; Guy Leverger; Patrizia Noris; Silverio Perrotta; Eric Solary; William Vainchenker; Najet Debili; Remi Favier; Hana Raslova
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

10.  Demonstration of novel gain-of-function mutations of αIIbβ3: association with macrothrombocytopenia and glanzmann thrombasthenia-like phenotype.

Authors:  Hirokazu Kashiwagi; Shinji Kunishima; Kazunobu Kiyomizu; Yoshiro Amano; Hiroyuki Shimada; Masashi Morishita; Yuzuru Kanakura; Yoshiaki Tomiyama
Journal:  Mol Genet Genomic Med       Date:  2013-04-22       Impact factor: 2.183

View more
  2 in total

1.  lncRNA-miRNA-mRNA ceRNA Network Involved in Sheep Prolificacy: An Integrated Approach.

Authors:  Masoumeh Sadeghi; Abolfazl Bahrami; Aliakbar Hasankhani; Hamed Kioumarsi; Reza Nouralizadeh; Sarah Ali Abdulkareem; Farzad Ghafouri; Herman W Barkema
Journal:  Genes (Basel)       Date:  2022-07-22       Impact factor: 4.141

2.  Network-Based Transcriptomic Analysis Identifies the Genetic Effect of COVID-19 to Chronic Kidney Disease Patients: A Bioinformatics Approach.

Authors:  Md Rabiul Auwul; Chongqi Zhang; Md Rezanur Rahman; Md Shahjaman; Salem A Alyami; Mohammad Ali Moni
Journal:  Saudi J Biol Sci       Date:  2021-06-10       Impact factor: 4.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.